The Munich District Court ruled in favor of Infineon Technologies, prohibiting Chinese company Innoscience from manufacturing, selling, and marketing products that infringe Infineon's patented gallium nitride (GaN) technology in Germany. This marks Innoscience's third and fourth legal defeat in similar cases, with courts in Germany and the U.S. confirming the infringement. Infineon, a leader in GaN technology with a broad patent portfolio, will receive damages and continues to pursue additional cases. The ruling strengthens Infineon's position in the semiconductor market, particularly in energy-efficient power systems for applications like renewable energy and electric vehicles.
Bronstein, Gewirtz & Grossman, LLC has opened an investigation into Gildan Activewear following a report accusing the company of inflating revenues by channel stuffing and obscuring financial details through off-balance sheet receivables. The report ...
Independent Bank Corporation (IBCP) has received shareholder approval from HCB Financial Corp. for its acquisition of Highpoint Community Bank. The deal, also approved by the Federal Reserve Bank of Chicago and Michigan regulators, is expected to clo...
Entergy Texas, a subsidiary of Entergy Corporation, announced a quarterly dividend of $0.3359375 per share on its Series A Preferred Stock. The dividend will be paid on July 15, 2026, to shareholders recorded as of July 2, 2026. This dividend reflect...
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...
